NEW YORK (GenomeWeb News) - Transgenomic will analyze mitochondrial DNA mutations for Salt Lake City-based Arup Laboratories, Transgenomic said yesterday.
Transgenomic's services include analysis of the whole mitochondrial genome and tools to detect mutations.
Arup vice president Noriko Kusukawa said mitochondrial diseases are difficult to diagnose, and that they affect around one in 8,500 individuals in the US.
Transgenomic president and CEO Craig Tuttle said the agreement will give a "critical diagnostic service to hundreds of patients with mitochondrial disorders."
Financial terms of the agreement were not released.